Screener
Design Therapeutics, Inc. DSGN Retained Earnings
Retained Earnings at other companies
Other financials
Where this comes from
Reported directly by Design Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.
The source filing: Design Therapeutics, Inc.’s 10-Q, filed April 28, 2026.
- Filed
- Apr 28, 2026, 4:13 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-187063
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Commitments and contingencies (See Note 8) | ||
| Stockholders’ equity: | ||
| Common stock, $0.0001 par value; 200,000,000 shares authorized at March 31, 2026 and December 31, 2025; 62,441,429 and 60,398,051 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively | 6 | 6 |
| Additional paid-in capital | 532,958 | 509,100 |
| Accumulated deficit | (314,642) | (297,006) |
| Accumulated other comprehensive (loss) income | (268) | 403 |
| Total stockholders’ equity | 218,054 | 212,503 |
| Total liabilities and stockholders’ equity | $230,442 | $226,203 |
Item 1. Financial Statements.
FAQ
- What is Design Therapeutics, Inc.'s retained earnings?
- Design Therapeutics, Inc. (DSGN) reported retained earnings of -$314.64M in Q1 2026.
- How has Design Therapeutics, Inc.'s retained earnings changed year-over-year?
- Design Therapeutics, Inc.'s retained earnings decreased by 28.5% year-over-year, from -$244.93M to -$314.64M.
- What is the long-term trend for Design Therapeutics, Inc.'s retained earnings?
- Over 5 years (2020 to 2025), Design Therapeutics, Inc.'s retained earnings has grown at a 90.2% compound annual growth rate (CAGR), from -$11.92M to -$297.01M.
- What does retained earnings mean?
- Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.
Ask your AI about Design Therapeutics, Inc.'s retained earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude